NPCE
Neuropace Inc
NASDAQ: NPCE · HEALTHCARE · MEDICAL DEVICES
$15.67
+2.77% today
Updated 2026-06-04
Market cap
$536.64M
P/E ratio
—
P/S ratio
5.39x
EPS (TTM)
$-0.65
Dividend yield
—
52W range
$8 – $20
Volume
0.2M
Neuropace Inc (NPCE) Insider transactions
Net insider activity
Net selling (5,131,359 shares)
Buy transactions
46
Sell transactions
54
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 358 | $17.06 | $6107.48 |
| 2026-05-27 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 1,126 | $17.06 | $19209.56 |
| 2026-05-15 | WILLIAMS, PATRICK F. | Chief Financial Officer | Buy | 44,800 | — | — |
| 2026-05-15 | WILLIAMS, PATRICK F. | Chief Financial Officer | Buy | 16,820 | — | — |
| 2026-05-15 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Buy | 14,550 | — | — |
| 2026-05-15 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Buy | 5,460 | — | — |
| 2026-05-15 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Buy | 122,190 | — | — |
| 2026-05-15 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Buy | 45,880 | — | — |
| 2026-03-24 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,341 | $13.27 | $17795.07 |
| 2026-03-20 | LACOB, JOSEPH | Director | Buy | 865 | $13.00 | $11245.00 |
| 2026-03-20 | KUMAR, RAKHI | Director | Buy | 1,153 | $13.00 | $14989.00 |
| 2026-03-20 | GEIGER, URI | Director | Buy | 913 | $13.00 | $11869.00 |
| 2026-03-20 | FISCHER, FRANK M | Director | Buy | 1,826 | $13.00 | $23738.00 |
| 2026-03-03 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,340 | $13.83 | $18532.20 |
| 2026-03-03 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 5,023 | $13.83 | $69468.09 |
| 2026-02-27 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 358 | $14.58 | $5219.64 |
| 2026-02-27 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 1,126 | $14.58 | $16417.08 |
| 2026-02-20 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,412 | $14.34 | $48928.08 |
| 2025-12-19 | LACOB, JOSEPH | Director | Buy | 678 | $16.59 | $11248.02 |
| 2025-12-19 | KUMAR, RAKHI | Director | Buy | 904 | $16.59 | $14997.36 |
| 2025-12-19 | GEIGER, URI | Director | Buy | 715 | $16.59 | $11861.85 |
| 2025-12-19 | FISCHER, FRANK M | Director | Buy | 1,431 | $16.59 | $23740.29 |
| 2025-12-15 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 25,000 | $15.97 | $399250.00 |
| 2025-12-03 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,338 | $16.66 | $22291.08 |
| 2025-11-27 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 357 | $16.50 | $5890.50 |
| 2025-11-27 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 1,126 | $16.50 | $18579.00 |
| 2025-11-20 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,051 | $13.50 | $41188.50 |
| 2025-09-19 | LACOB, JOSEPH | Director | Buy | 1,131 | $9.94 | $11242.14 |
| 2025-09-19 | KUMAR, RAKHI | Director | Buy | 1,509 | $9.94 | $14999.46 |
| 2025-09-19 | GEIGER, URI | Director | Buy | 1,194 | $9.94 | $11868.36 |
| 2025-09-19 | FISCHER, FRANK M | Director | Buy | 2,389 | $9.94 | $23746.66 |
| 2025-09-03 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,337 | $9.36 | $12514.32 |
| 2025-08-27 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 357 | $8.88 | $3170.16 |
| 2025-08-27 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 1,126 | $8.88 | $9998.88 |
| 2025-08-20 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,052 | $8.66 | $26430.32 |
| 2025-06-21 | LACOB, JOSEPH | Director | Buy | 1,080 | $10.41 | $11242.80 |
| 2025-06-21 | KUMAR, RAKHI | Director | Buy | 1,440 | $10.41 | $14990.40 |
| 2025-06-21 | GEIGER, URI | Director | Buy | 1,140 | $10.41 | $11867.40 |
| 2025-06-21 | FISCHER, FRANK M | Director | Buy | 2,281 | $10.41 | $23745.21 |
| 2025-06-20 | WILLIAMS, PATRICK F. | Chief Financial Officer | Buy | 87,950 | — | — |
| 2025-06-20 | WILLIAMS, PATRICK F. | Chief Financial Officer | Buy | 51,850 | — | — |
| 2025-06-06 | RYAN, RENEE | Director | Buy | 8,745 | — | — |
| 2025-06-06 | LACOB, JOSEPH | Director | Buy | 8,745 | — | — |
| 2025-06-06 | KUMAR, RAKHI | Director | Buy | 8,745 | — | — |
| 2025-06-06 | HUENNEKENS, R SCOTT | Director | Buy | 8,745 | — | — |
| 2025-06-06 | GEIGER, URI | Director | Buy | 8,745 | — | — |
| 2025-06-06 | FISCHER, FRANK M | Director | Buy | 8,745 | — | — |
| 2025-06-06 | ANDRADE, LISA | Director | Buy | 8,745 | — | — |
| 2025-06-03 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,338 | $13.54 | $18116.52 |
| 2025-06-03 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Sale | 1,337 | $13.54 | $18102.98 |
| 2025-05-27 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 357 | $12.66 | $4519.62 |
| 2025-05-27 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Sale | 357 | $12.66 | $4519.62 |
| 2025-05-27 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 1,126 | $12.66 | $14255.16 |
| 2025-05-20 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,051 | $17.99 | $54887.49 |
| 2025-05-20 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Sale | 3,051 | $17.99 | $54887.49 |
| 2025-05-14 | ORBIMED, ADVISORS LLC | 10% Owner | Sale | 134,136 | $15.83 | $2.12M |
| 2025-05-14 | ORBIMED, ADVISORS LLC | 10% Owner | Sale | 34,000 | $15.94 | $541960.00 |
| 2025-04-22 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 237 | $10.94 | $2592.78 |
| 2025-04-22 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Sale | 237 | $10.94 | $2592.78 |
| 2025-03-24 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Buy | 19,850 | — | — |
| 2025-03-24 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Buy | 11,700 | — | — |
| 2025-03-21 | LACOB, JOSEPH | Director | Buy | 935 | $12.02 | $11238.70 |
| 2025-03-21 | KUMAR, RAKHI | Director | Buy | 1,247 | $12.02 | $14988.94 |
| 2025-03-21 | GEIGER, URI | Director | Buy | 987 | $12.02 | $11863.74 |
| 2025-03-21 | FISCHER, FRANK M | Director | Buy | 1,975 | $12.02 | $23739.50 |
| 2025-03-10 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Buy | 19,850 | — | — |
| 2025-03-10 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Buy | 11,700 | — | — |
| 2025-03-10 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Buy | 99,200 | — | — |
| 2025-03-10 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Buy | 58,500 | — | — |
| 2025-03-03 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,337 | $11.81 | $15789.97 |
| 2025-03-03 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Sale | 1,337 | $11.81 | $15789.97 |
| 2025-02-27 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,430 | $12.56 | $17960.80 |
| 2025-02-27 | KUHN, REBECCA | CHIEF FINANCIAL OFFICER | Sale | 1,430 | $12.56 | $17960.80 |
| 2025-02-27 | BECKER, JOEL | Director, CHIEF EXECUTIVE OFFICER | Sale | 4,506 | $12.56 | $56595.36 |
| 2025-02-21 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 78,334 | $13.72 | $1.07M |
| 2025-02-20 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,405 | $14.23 | $48453.15 |
| 2025-02-20 | KUHN, REBECCA | Chief Financial Officer | Sale | 3,405 | $14.23 | $48453.15 |
| 2025-02-20 | KCK, LTD. | 10% Owner | Sale | 5,270,845 | $9.40 | $49.55M |
| 2025-01-30 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 200 | $15.00 | $3000.00 |
| 2025-01-29 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 100 | $15.00 | $1500.00 |
| 2025-01-24 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,200 | $15.01 | $48032.00 |
| 2025-01-22 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 265 | $14.04 | $3720.60 |
| 2025-01-22 | KUHN, REBECCA | Chief Financial Officer | Sale | 265 | $14.04 | $3720.60 |
| 2025-01-06 | HUENNEKENS, R SCOTT | Director | Buy | 15,507 | — | — |
| 2024-12-21 | LACOB, JOSEPH | Director | Buy | 975 | $11.53 | $11241.75 |
| 2024-12-21 | KUMAR, RAKHI | Director | Buy | 1,300 | $11.53 | $14989.00 |
| 2024-12-21 | GEIGER, URI | Director | Buy | 1,029 | $11.53 | $11864.37 |
| 2024-12-21 | FISCHER, FRANK M | Director | Buy | 2,059 | $11.53 | $23740.27 |
| 2024-12-03 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 1,413 | $11.93 | $16857.09 |
| 2024-12-03 | KUHN, REBECCA | Chief Financial Officer | Sale | 1,334 | $11.93 | $15914.62 |
| 2024-11-20 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 3,045 | $9.19 | $27983.55 |
| 2024-11-20 | KUHN, REBECCA | Chief Financial Officer | Sale | 3,045 | $9.19 | $27983.55 |
| 2024-10-25 | KCK, LTD. | 10% Owner | Sale | 223,991 | $5.45 | $1.22M |
| 2024-10-23 | KCK, LTD. | 10% Owner | Sale | 147 | $6.02 | $884.94 |
| 2024-10-22 | MORRELL, MARTHA | CHIEF MEDICAL OFFICER | Sale | 237 | $6.00 | $1422.00 |
| 2024-10-22 | KUHN, REBECCA | Chief Financial Officer | Sale | 237 | $6.00 | $1422.00 |
| 2024-10-22 | KCK, LTD. | 10% Owner | Sale | 4,082 | $6.09 | $24853.26 |
| 2024-10-21 | KCK, LTD. | 10% Owner | Sale | 3,720 | $6.10 | $22678.61 |
| 2024-10-18 | KCK, LTD. | 10% Owner | Sale | 4,878 | $6.29 | $30691.89 |
| 2024-10-17 | KCK, LTD. | 10% Owner | Sale | 3,294 | $6.28 | $20686.32 |
Frequently asked questions
Are NPCE insiders buying or selling?
Over the transactions on record, NPCE insiders have been net sellers, with about $55.89M in stock sold across 54 sales, against 24 open-market purchases.
Does insider selling at NPCE mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which NPCE insiders are selling the most?
Recent selling is concentrated in a few names. KCK, LTD. accounts for the largest share on record, with about $50.87M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.